Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: Metabolic activity and therapeutic range

Tissue Engineering

Volumn 4, Issue 4, 1998, Pages 403-414

  Mansbridge, Jonathan ^a   Liu, Rang ^a   Patch, Ruth ^a   Symons, Kent ^a   Pinney, Emmett ^a  

^a Advanced Tissue Sciences Liquidating Trust   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL TRANSPLANTATION; CELL VIABILITY; DIABETES MELLITUS; DIABETIC FOOT; FIBROBLAST; FOOT ULCER; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WOUND HEALING;

EID: 0031759930     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1998.4.403     Document Type: Article

References (26)

1. Naughton, O.K., and Tolbert, W.R. Tissue engineering: skin. In: R.P. Lanza and W.L. Chick, eds. Yearbook of Cell and Tissue Transplantation. The Netherlands: Kluwer Academic Publishers, pp. 265-274, 1996.
2. Levin, M.E. Pathogenesis and management of diabetic foot lesions. In: M.E. Levin, L.W. O'Neal, and J.H. Bowker, eds. The Diabetic Foot. St. Louis: Mosby Year Book, pp. 17-60, 1993.
3. Flynn, M.D., and Tooke, J.E. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabet. Med. 9, 320, 1992.
4. Gugliucci, A., and Bendayan, M. Histones from diabetic rats contain increased levels of advanced glycation end products. Biochem. Biophys. Res. Commun. 212, 56, 1995.
5. Ido, Y., Kilo, C., and Williamson, J.R. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction. Nephrol. Dial. Transplant. 11, 72, 1996.
6. Skolnik, E:Y., and Marcusohn, J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev. 7, 161, 1996.
7. Yamagata, K., Oda, N., Kaisaki, P.J., et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity onset diabetes of the young (MODY3). Nature 384, 455, 1996.
8. Yamagata, K., Funuta, H., Oda, N., et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity onset diabetes of the young (MODY1). Nature 384, 458, 1996.
9. Naughton, G.K., Mansbridge, J.N., and Gentzkow, G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif. Organs 21, 1203, 1997.
10. Pollak, R.A., Erington, H., Jensen, J.L., et al. A human dermal replacement for the treatment of diabetic foot ulcers. Wounds 9, 175, 1997.
11. Smith, M.D., Barbanel, J.C., Courtney, J.M., et al. Novel quantitative methods for the determination of biomaterial cytotoxicity. Int. J. Artif. Organs 15, 191, 1992.
12. Lomonte, B., Gutierrez, J.M., Romero, M., et al. An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. J. Immunol. Methods 161, 231, 1993.
13. Downs, T.R., and Wilfinger, W.W. Fluorometric quantification of DNA in cells and tissue. Anal. Biochem. 131, 538, 1983.
14. Junquiera, L.C.U., Bignolas, G., and Brentani, R.R. A simple and sensitive method for the quantitative estimation of collagen. Anal. Biochem. 94, 96, 1979.
15. Farndale, R.W., Sayers, C.A., and Barrett, A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9, 247, 1982.
16. Fleck, A., and Munro, H.N. The precision of ultraviolet absorption measurement in the Schmidt-Thannhauser procedure for nucleic acid estimation. Biochim. Biophys. Acta 55, 571, 1962.
17. Heid, C.A., Stevens, J., Livak, K.J., et al. Real-time quantitative PCR. Genome Res. 6, 986, 1996.
18. Barnhill, R.L., and Ryan, T.J. Biochemical modulation of angiogenesis in the chorioallantoic membrane of the chick embryo. J. Invest. Dermatol. 81, 485, 1983.
19. Jakob, W., Jentsch, K.D., Mauersberger, B., et al. The chick embryo choriallantoic membrane as a bioassay for angiogenesis factors: reactions induced by carrier materials. Exp. Pathol. (Jena) 15, 241, 1978.
20. Vistica, D.T., Skehan, P., Scudiero, D., et al. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51, 2515, 1991.
21. Hubner, G., Breier, G., Longaker, M.T., et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270, 12607, 1995.
22. Beer, H.-D., Longaker, M.T., and Werner, S. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J. Invest. Dermatol. 109, 132, 1997.
23. Levin, M. Diabetic foot wounds: pathogenesis and management. Adv. Wound Care 10, 24, 1997.
24. Bell, E., Sher, S., and Hull, B. The living skin-equivalent as a structural and immunological model in skin grafting. Scanning Electron Microsc. 1957, 1984.
25. Parenteau, N.L., Nolle, C.M., Bilbo, P., et al. Epidermis generated in vitro: practical considerations and applications. J. Cell. Biochem. 45, 245, 1991.
26. Nusgens, B., Merril, C., Lapiere, C., et al. Collagen biosynthesis by cells in a tissue equivalent matrix in vitro. Collagen Rel. Res. 4, 351, 1984.